On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Signs CPG Sales Agency, Eyes Expansion and Growth

  • TAAT(TM) partnered with CROSSMARK based on powerful formula for creating, implementing and executing strategies for CPG merchandising
  • Of particular interest is CROSSMARK’S success in commercializing tobacco alternatives that achieved dominant e-cigarette market share
  • TAAT committed to growing innovative tobacco-free, nicotine-free alternative to traditional cigarettes

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF), a life science company dedicated to giving legal-aged smokers a nicotine- and tobacco-free smoking experience, recently unveiled TAAT(TM), its flagship product — and the product has been greeted with an exceptional response. Representative of the interest shown in the product — and the promising future of the innovative smoking alternative — is the agreement TAAT recently signed with CROSSMARK, an omnichannel CPG sales agency.

“Ever since TAAT was first placed on store shelves in Ohio in December 2020, we have received glowing feedback about the product from both legal-aged smokers and retailers alike,” said TAAT CEO Setti Coscarella. “It is common knowledge in the world of business that this is only the first step towards the success of a product launch. We selected CROSSMARK to represent TAAT because their formula for creating, implementing and executing strategies for CPG merchandising has been honed over decades of bringing new consumer products to mainstream retail channels.”

Through CROSSMARK, all three TAAT varieties — Original, Smooth and Menthol —may be available at more than 100,000 convenience stores located throughout the country. CROSSMARK, a sales and merchandising agency for CPG products, has established relationships with major retailers across all channels. Of particular interest to TAAT is CROSSMARK’S success in commercializing tobacco alternatives that achieved dominant e-cigarette market share in the United States.

“At CROSSMARK, we pride ourselves in our familiarity with what intrigues today’s consumers and what consistently delivers value to them,” said Jeff Neihart. CROSSMARK vice president and general manager of customer service. “We are very selective in onboarding only a limited number of new brands each year, and it gives me great satisfaction to have found a match in TAAT as a novel, relevant, and ‘sticky’ product that could continue to resonate well with legal-aged smokers.

“Furthermore, we are confident that with the combination of our presence in the retail channels through which tobacco products are sold and our experience in executing strategies within the category of tobacco alternatives, we can amplify the value proposition offered by TAAT to legal-aged smokers in the United States and help the company meet or exceed their goals,” Neihart continued. “CROSSMARK has been in the business of connecting retailers with a curated range of CPG products for more than 100 years, and we are excited to introduce TAAT to tobacco retailers who we predict will find the product appealing and will want to carry it in their respective stores.”

According to the agreement, in addition to introducing TAAT to potential wholesale and retail locations, CROSSMARK will provide an in-field execution team focused on supporting in-store acceptance, merchandising and reorders of TAAT products. The company will also provide TAAT with extensive promotional, trade marketing and analytics support as the two companies partner together to make the most of existing initiatives and evaluate the possibilities for national growth and expansion.

“In addition to leveraging their relationships with major retailers and wholesalers across our targeted channels for TAAT, CROSSMARK also offers an impressive suite of ‘back office’ functions including marketing, data analytics, and order processing support,” said Coscarella. “Altogether, these services could enable TAAT to penetrate the tobacco market much more rapidly and efficiently compared to building out our own national sales and merchandising team from scratch. One only has to look at the results CROSSMARK achieved in commercializing another tobacco brand across the United States to know that they have both the experience and know-how to launch a product to an audience of legal-aged smokers, which could assist the company in realizing its objectives for the TAAT product launch. We are thrilled to have CROSSMARK on our side as we seek to make TAAT products available to legal-aged smokers throughout the United States.”

TAAT has developed TAAT, a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched in the United States in Q4 2020 and is focused on positioning itself in the $814 billion global tobacco industry.

For more information, visit the company’s website at www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

From Our Blog

Largely Untapped Market for Hallucinogenic Draws Attention of Researchers at XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

April 16, 2021

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profile Mescaline is illegal under U.S. federal law, but some state-centric efforts to legalize or decriminalize the hallucinogenic have launched in a manner similar to the populace effort […]

Rotate your device 90° to view site.